David A. Rosa - Feb 17, 2023 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
Director
Signature
/s/ David A. Rosa
Stock symbol
BRTX
Transactions as of
Feb 17, 2023
Transactions value $
$0
Form type
4
Date filed
2/17/2023, 04:38 PM
Previous filing
Feb 7, 2023
Next filing
Mar 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BRTX Stock Option Award $0 +32K $0.00 32K Feb 17, 2023 Common Stock 32K $2.91 Direct F2
holding BRTX Stock Option 10.5K Feb 17, 2023 Common Stock 10.5K $5.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in eight nearly-equal, quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested.
F2 The option vests and becomes exercisable in twelve monthly installments of 2,669 shares beginning on March 17, 2023 and continuing every month thereafter until fully vested.